发明名称 NUCLEIC ACID MARKERS FOR USE IN DETERMINING PREDISPOSITION TO NEOPLASM AND/OR ADENOMA
摘要 The present invention relates generally to novel nucleic acid molecules, the levels and/or patterns of expression of which are indicative of the onset, predisposition to the onset and/or progression of a neoplasm and to derivatives, homologues or analogues of said molecules. More particularly, the present invention is directed to novel nucleic acid molecules, the levels of expression of which are indicative of the onset and/or progression of a gastrointestinal tract neoplasm, such as an adenoma, and to derivatives, homologues or analogues of said molecules. The present invention is further directed to isolated proteins encoded thereby and to derivatives, homologues, analogues, chemical equivalents and mimetics thereof. The molecules of the present invention are useful in a range of prophylactic, therapeutic and/or diagnostic applications including, but not limited to, those relating to the diagnosis and/or treatment of colorectal neoplasms such as colorectal adenomas. In a related aspect, the present invention is directed to a method of screening a subject for the onset, predisposition to the onset and/or progression of a neoplasm by screening for modulation in the level of expression of one or more nucleic acid molecule markers.
申请公布号 EP1438427(B1) 申请公布日期 2016.04.20
申请号 EP20020757979 申请日期 2002.09.13
申请人 CLINICAL GENOMICS PTY. LTD 发明人 JAMES, ROBERT;HENRY, JULIANNE;KAZENWADEL, JAN;VAN HOST PELLEKAAN, NICK;MACPHERSON, ANNE;O'CONNOR, SUSAN
分类号 C12Q1/68;C07H21/04;C07K14/435;C07K14/47;C12N15/11 主分类号 C12Q1/68
代理机构 代理人
主权项
地址